Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • SGLT2 inhibitors

Clear, simple language improves patient safety

    • Cardiology
    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nephrology
    • Prevention and health care
    • RX
    • Studies
  • 5 minute read

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) were initially indicated as blood glucose-lowering drugs for type 2 diabetes. They are now widely used as first-line therapies for various indications, particularly heart failure and chronic kidney disease. Although their growing importance is increasingly supported by data from clinical trials, their specific side effect profile requires thorough patient education to ensure safe and effective use.

Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich
Jetzt beitreten
Already a member? Log in here
Autoren
  • Jens Dehn
Publikation
  • InFo DIABETOLOGIE & ENDOKRINOLOGIE
Related Topics
  • Adherence
  • Blood sugar reduction
  • Chronic kidney disease
  • Compliance
  • Heart failure
  • SGLT2 inhibitors
  • Side effect profile
  • Sodium-glucose cotransporter 2 inhibitors
  • Type 2 diabetes
Previous Article
  • Moderate to severe atopic dermatitis

Established and novel biologics – the therapeutic landscape is in flux

  • Allergology and clinical immunology
  • Dermatology and venereology
  • Education
  • RX
  • Studies
View Post
Next Article
  • Seborrheic dermatitis in adults

Do not underestimate the symptom burden

  • Allergology and clinical immunology
  • Dermatology and venereology
  • Education
  • Pharmacology and toxicology
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 5 min
  • Case study

Autosomal recessive polycystic kidney disease: atypical phenotype

    • Cases
    • Education
    • Gastroenterology and Hepatology
    • Genetics
    • Nephrology
    • RX
View Post
  • 12 min
  • Current evidence, risk classes and new counseling options

Hormonal contraception and cardiovascular risk

    • Cardiology
    • Education
    • Gynecology
    • Neurology
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 4 min
  • Acute otitis media: self-limiting course vs. "red flags"

In which cases are antibiotics necessary?

    • Congress Reports
    • General Internal Medicine
    • Infectiology
    • ORL
    • Pediatrics
    • RX
View Post
  • 6 min
  • Prurigo nodularis: evidence-based treatment

Targeted therapy options on the rise

    • Allergology and clinical immunology
    • Dermatology and venereology
    • Education
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 13 min
  • MACE risk, heart failure incidence and all-cause mortality

Metabolic syndrome as a cardiovascular risk factor

    • Cardiology
    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • RX
    • Studies
View Post
  • 9 min
  • Glaucoma in old age: slowing down progression

IOP lowering is currently the only evidence-based treatment

    • Education
    • General Internal Medicine
    • Ophthalmology
    • Prevention and health care
    • RX
    • Studies
View Post
  • 7 min
  • Vector-borne infections with skin manifestations

Arboviruses and leishmaniasis in Europe

    • Congress Reports
    • Infectiology
    • Prevention and health care
    • RX
    • Studies
    • Tropical and travel medicine
View Post
  • 6 min
  • Multimorbidity and functional capacity in old age

Clarify individual health status and reduce risks

    • Congress Reports
    • General Internal Medicine
    • Geriatrics
    • Neurology
    • Orthopedics
    • Physical medicine and rehabilitation
    • Prevention and health care
    • Rheumatology
    • RX
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Do special amino acids lead to success?
  • 2
    Current status of PAT
  • 3
    Surgical wound complications
  • 4
    Do special amino acids lead to success?
  • 5
    Functional limb preservation between infection control, vascular medicine and resurfacing

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.